5-Amino-1MQ – Research Overview

Research Use Only

All compounds discussed here are for educational and research purposes only. Not for human use. Not medical advice.
5-Amino-1MQ is not a prescription drug. It is discussed strictly as a research compound.


1. What It Is

5-Amino-1MQ is a small-molecule research compound that targets metabolic pathways involved in fat storage and cellular energy usage.
It is not a peptide but is often grouped with metabolic research agents due to its role in adipocyte studies.


2. How It Works (Mechanism of Action)

Research suggests that 5-Amino-1MQ may:
• Inhibit the enzyme nicotinamide N-methyltransferase (NNMT)
• Influence how fat cells store and burn energy
• Support improved cellular energy efficiency
• Reduce adipocyte size in experimental models

The NNMT pathway is associated with energy regulation, mitochondrial efficiency, and metabolic rate.


3. Potential Research Uses

• Fat-loss and body-composition modeling
• Adipocyte metabolism studies
• Energy-balance and mitochondrial-function research
• Metabolic-efficiency modulation in laboratory systems


4. Key Potential Benefits (Research Context)

• Reduced fat-mass signals in experimental models
• Improved metabolic efficiency
• Possible increase in NAD+ levels indirectly via NNMT inhibition
• Support for lean-mass preservation during caloric deficit models


5. Potential Side Effects & Risks

• Mild headaches
• Temporary digestive discomfort
• Possible restlessness or insomnia (if taken late in the day)
• Limited human data
• Unknown long-term safety

Human data is limited. Long-term safety is unknown.


6. Typical Research Dosing & Cycles

Not dosing advice — research context only.

Common research patterns involve:
• Oral capsule or powdered form
• 50–150 mg daily in various experimental setups
• 4–8 week cycles in early research models
• Often followed by off-cycles for observation

Again, dosing varies widely and is not standardized.


7. Stacks & Combinations (Research Discussion)

Commonly discussed alongside:
• GLP-1 or GLP-2 agents in metabolic studies
• AOD-9604 in fat-metabolism modeling
• Exercise and caloric-deficit research environments

Caution: stacking metabolic compounds increases variability and potential risk.


8. Bloodwork & Monitoring Considerations

Researchers often track:
• Fasting glucose and insulin
• Lipid panel
• Liver and kidney function
• Weight, waist circumference, and body-composition metrics

Only a qualified healthcare provider may interpret labs.


9. Tags & Category

Primary tag(s): 5-amino-1mq, library
Discussion link: Talk about this peptide »


10. References & Further Reading

• NNMT inhibition research
• Studies on adipocyte-size regulation
• Metabolic small-molecule modulators
• Reviews on energy-balance pathways